![A Technical Feasibility Study of Dornase Alfa Delivery with eFlow® Vibrating Membrane Nebulizers: Aerosol Characteristics and Physicochemical Stability - ScienceDirect A Technical Feasibility Study of Dornase Alfa Delivery with eFlow® Vibrating Membrane Nebulizers: Aerosol Characteristics and Physicochemical Stability - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S002235491532325X-gr1.jpg)
A Technical Feasibility Study of Dornase Alfa Delivery with eFlow® Vibrating Membrane Nebulizers: Aerosol Characteristics and Physicochemical Stability - ScienceDirect
![Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection - ScienceDirect Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2052297520301086-gr7.jpg)
Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection - ScienceDirect
![These highlights do not include all the information needed to use PULMOZYME safely and effectively. See full prescribing information for PULMOZYME. PULMOZYME® (dornase alfa) inhalation solution, for inhalation use Initial U.S. Approval: These highlights do not include all the information needed to use PULMOZYME safely and effectively. See full prescribing information for PULMOZYME. PULMOZYME® (dornase alfa) inhalation solution, for inhalation use Initial U.S. Approval:](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=pulmozyme-44.jpg&id=638478)